Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, announced that the Board has appointed Dr Alessandro Riva, MD, as the Company’s new Chairman and CEO to accelerate the development of its innovative immunotherapy portfolio.
Norlase, a leading global ophthalmic laser manufacturer developing next-generation laser solutions, announced it has received both FDA 510 clearance and CE Mark approval for the ECHO Green Pattern Laser photocoagulator.
Norlase Receives FDA 510(k) Clearance and CE Mark Approval For ECHO™ Green Pattern Laser Read More »
Los resultados de casi 3 millones de mujeres sugieren que es poco probable un efecto causal, dicen los expertos
Javier Arias Díaz, Catedrático de Cirugía de la Universidad Complutense de Madrid (UCM), dialogó en exclusiva con IntraMed.
COVID-19 dropped out of the top five telehealth diagnoses nationally, with mental health conditions claiming the top spot.
Telehealth declined nationally in February, Fair Health finds Read More »
Rising expenses and thin operating margins have left hospitals vulnerable to a potential recession or a new public health emergency.
Hospital margins continue to stabilize but remain below pre-pandemic levels Read More »
The company said revenue increases in a number of its product lines were faster than market growth rates, suggesting it’s gaining share.
BD raises full-year forecasts again, expects Alaris infusion pump approval Read More »
The company aims to expand its video game-based treatment for ADHD to adults and adolescents.
Analysts at Cowen said the draft could reassure sponsors they can run decentralized trials without complicating approvals.
FDA posts draft guidance on studying medical devices in decentralized clinical trials Read More »
Bright’s current SVP of finance Jay Matushak is stepping up after current CFO Cathy Smith elected to leave the post to pursue a new opportunity, the company said Wednesday.
